Ontario Researchers Collaborate to Study Acai Berry Palm Extract as an Intervention in COVID-19 Patients
Faculty News
COVID-19 causes many disturbances in the human body, which can lead to complications including excessive inflammation. Studies have indicated that the extract of the acai berry may act as an inhibitor of inflammation, but more research is needed. Dr. Ana Andreazza of Pharmacology and Toxicology, and Dr. Michael Dr. Farkouh, Chair & Director of the Peter Munk Centre of Excellence in Multinational Clinical Trials at UHN, are collaborating to test whether an early intervention of acai palm berry extract can improve the recovery of patients with COVID-19 and help to prevent complications caused by inflammation.
